Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

SANDOZ

  • FDA Approval
  • Sept. 09, 2024, 08:38 UTC
  • 48
  • 0 comments

FDA approve HYDROXYCHLOROQUINE SULFATE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 09, 2024, 08:38 UTC
  • 56
  • 0 comments

FDA approve TICAGRELOR

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • Sept. 09, 2024, 04:15 UTC
  • 55
  • 0 comments

FDA approve THEOPHYLLINE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 09, 2024, 04:15 UTC
  • 61
  • 0 comments

FDA approve EFAVIRENZ; EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Comment Full text

PACIRA PHARMS INC

  • FDA Approval
  • Sept. 06, 2024, 19:08 UTC
  • 57
  • 0 comments

FDA approve TRIAMCINOLONE ACETONIDE

Comment Full text

USWM

  • FDA Approval
  • Sept. 06, 2024, 19:08 UTC
  • 57
  • 0 comments

FDA approve LOFEXIDINE HYDROCHLORIDE

Comment Full text

HIKMA

  • FDA Approval
  • Sept. 06, 2024, 08:52 UTC
  • 55
  • 0 comments

FDA approve DESVENLAFAXINE SUCCINATE

Comment Full text

HIKMA

  • FDA Approval
  • Sept. 06, 2024, 08:52 UTC
  • 53
  • 0 comments

FDA approve DESVENLAFAXINE SUCCINATE

Comment Full text

ALEMBIC

  • FDA Approval
  • Sept. 06, 2024, 08:52 UTC
  • 56
  • 0 comments

FDA approve ALBENDAZOLE

Comment Full text

BAXTER HLTHCARE

  • FDA Approval
  • Sept. 06, 2024, 08:52 UTC
  • 48
  • 0 comments

FDA approve CYCLOPHOSPHAMIDE

Comment Full text
  • Previous
  • 360
  • 361
  • 362
  • 363
  • 364
  • Next

Search

News categories

  • Technical Exchange News(11504)
  • Event(3374)
  • SEC News(216353)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(137524)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin